Overview
The Value of Increasing Diversity in Clinical Trials
The underrepresentation of diverse populations in clinical trials creates knowledge gaps about the risks and benefits of drugs and devices for the public.
CTTI is addressing the value of including diverse patient populations in clinical trials throughout the development lifecycle of medical products—from early target identification through clinical trial conduct to increase research discoveries is vital. Forthcoming recommendations and resources will help stakeholders adopt new organizational level practices that increase diversity in clinical trials and, thereby, better identify population-level differences in treatment response, safety, and efficacy.
Quick Links to Top Deliverables
Project Team Members
Role |
Name | Affiliation |
|---|---|---|
| EC Champion | Robert Temple | Food and Drug Administration/CDER |
| Project Manager | Sara Calvert | Clinical Trials Transformation Initiative |
| Team Leader | Luther Clark | Merck & Company, Inc |
| Team Leader | Dawn Corbett | National Institutes of Health |
| Team Leader | Tesheia Johnson | Yale University |
| Team Leader | Bernadete Siddiqi | The Michael J Fox Foundation for Parkinson's Research |
| Team Leader | Richardae Araojo | Food and Drug Administration/OC |
| Team Member | Cecelia Belamonte | Amgen Inc |
| Team Member | Melania Boyce | EMD Serono |
| Team Member | Christina Brennan | Northwell Health |
| Team Member | Susan Burriss | GlaxoSmithKline |
| Team Member | Kimberly Fisher | Janssen |
| Team Member | Diana Foster | Society for Clinical Research Sites |
| Team Member | Natalie Holick | University of Kansas Medical Center |
| Team Member | Patricia Jones | National Institutes of Health |
| Team Member | Beverly Lorell | King & Spalding LLP |
| Team Member | Suzanne Maahs | Novartis |
| Team Member | Jerrihlyn McGee | University of Kansas Medical Center |
| Team Member | Coleman Obasaju | Eli Lilly and Company |
| Team Member | Kelley O'Donoghue | University of Rochester |
| Team Member | Heidi Pereira | Novartis |
| Team Member | Karlin Schroeder | Parkinson's Foundation |
| Team Member | Jeffrey Sherman | Drug Information Association |
| Team Member | Kevin Thomas | Duke University |
| Team Member | Jane Williams | Syneos Health |
| Team Member | Julia Yegorova | Genentech-a member of the Roche Group |
| Team Member | Glendon Zinser | Susan G Komen |
| Team Member | Kaveeta Vasisht | Food and Drug Administration/OC |
| Team Member | Arisha Ali | Amgen Inc |
| Team Member | Ruma Bhagat | Genentech-a member of the Roche Group |
| Team Member | Maria Ali | The George Institute for Global Health |
| Team Member | Patricia Hurley | American Society of Clinical Oncology |
| Team Member | Jaime Arango | CITI Program, a Division of BRANY |
| Team Member | Jamil Rivers | Individual Patient/Caregiver |
| Team Member | Cassandra Smith | Johnson & Johnson/Janssen |
| Team Member | Kimberly Carlson | Department of Veterans Affairs |
| Team Member | Cassandra Beisel | Melanoma Research Foundation |